Company intelligence / Profile preview

Panion & BF Biotech Inc.

Ownership: Public · 1760
Employees: ~321
Development stage: Commercial

Overview

Panion & BF Biotech has successfully developed Nephoxil®—a phosphate binder approved in Taiwan, Japan, the US—for hyperphosphatemia in ESRD. The company has a diversified portfolio including APIs and cosmeceuticals. Several clinical trials have been completed for ferric citrate-based therapies; some programs have been discontinued or are pending further development. The company leverages global partnerships to commercialize its products across Asia-Pacific and beyond.[5][6][9]

Therapeutic areas: Women's HealthHematologyOncologyNephrology
Modalities: Small molecules (notably phosphate binders)Active pharmaceutical ingredients (APIs)Cosmeceuticals and nutraceuticals
Industry: Biotech

Drug pipeline

1 asset

NEPHRIL

Preclinical

Partnerships

Keryx Pharmaceuticals—license agreement for Nephoxil®/Zerenex™ development outside Asia-PacificJapan Tobacco/Torii—sub-license for Japan marketVarious OEM/ODM partners across Asia-Pacific.[5][6]

Financials

Market cap: $128.1M
Total revenue: $63M
Enterprise value: $132.1M

Beyond the preview

Go deeper on Panion & BF Biotech Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panion & BF Biotech Inc..